|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-294 |
1.23e-96 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 286.36 E-value: 1.23e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEq 80
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAG- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 eHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFGKLA 160
Cdd:COG1597 81 -TGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 161 YFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLK 240
Cdd:COG1597 160 YVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLR 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 488302628 241 GVDGSTKNLAYLTCEQLVVSLadEEELTTNVDGDE-GDKLPVNIKVLPSHLQVYC 294
Cdd:COG1597 240 GRHLRHPGVRYFRAREVEIES--DRPLPVQLDGEPlGLATPLEFEVLPGALRVLV 292
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
1-294 |
1.21e-71 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 223.00 E-value: 1.21e-71
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:PRK13337 1 MKRARIIYNPTSGRELFKKNLPDVLQKLEQAGYETSAHATTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIAEK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFGKLA 160
Cdd:PRK13337 81 ENRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQLA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 161 YFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLK 240
Cdd:PRK13337 161 YYLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLAPDASLDDGYFDLIIVKKANLAELIHIATLALR 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 488302628 241 GVDGSTKNLAYLTCEQLVVSLADEEELttNVDGDEGDKLPVNIKVLPSHLQVYC 294
Cdd:PRK13337 241 GEHIKHPKVIYTKANRIKVSSFDKMQL--NLDGEYGGKLPAEFENLYRHIEVFV 292
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-292 |
1.52e-58 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 189.25 E-value: 1.52e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALIQL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDY-FMNVVAIGSIPEAINDVDAEKKTKFGKL 159
Cdd:TIGR00147 81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 160 AYFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLL 239
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPALVLTLMSD 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 488302628 240 KGVDGSTKNLAYLTCEQlvVSLADEEELTTNVDGDEGDKLPVNIKVLPSHLQV 292
Cdd:TIGR00147 241 EGKHTDNPNIIYGKASR--IDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-127 |
5.82e-43 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 143.49 E-value: 5.82e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 3 KVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQEH 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....*
gi 488302628 83 RPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKI 127
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGKV 125
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-108 |
1.13e-13 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 66.55 E-value: 1.13e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 5 LLVVNPSSGGEQAKEFeqlaIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQE--- 81
Cdd:smart00046 1 LVFVNPKSGGGKGEKL----LRKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRElpl 76
|
90 100
....*....|....*....|....*..
gi 488302628 82 HRPNFGFFPLGTVNDLARALGIPLEPE 108
Cdd:smart00046 77 PEPPVAVLPLGTGNDLARSLGWGGGYD 103
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-294 |
1.23e-96 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 286.36 E-value: 1.23e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEq 80
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAG- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 eHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFGKLA 160
Cdd:COG1597 81 -TGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 161 YFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLK 240
Cdd:COG1597 160 YVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLR 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 488302628 241 GVDGSTKNLAYLTCEQLVVSLadEEELTTNVDGDE-GDKLPVNIKVLPSHLQVYC 294
Cdd:COG1597 240 GRHLRHPGVRYFRAREVEIES--DRPLPVQLDGEPlGLATPLEFEVLPGALRVLV 292
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
1-294 |
1.21e-71 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 223.00 E-value: 1.21e-71
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:PRK13337 1 MKRARIIYNPTSGRELFKKNLPDVLQKLEQAGYETSAHATTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIAEK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFGKLA 160
Cdd:PRK13337 81 ENRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQLA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 161 YFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLK 240
Cdd:PRK13337 161 YYLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLAPDASLDDGYFDLIIVKKANLAELIHIATLALR 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 488302628 241 GVDGSTKNLAYLTCEQLVVSLADEEELttNVDGDEGDKLPVNIKVLPSHLQVYC 294
Cdd:PRK13337 241 GEHIKHPKVIYTKANRIKVSSFDKMQL--NLDGEYGGKLPAEFENLYRHIEVFV 292
|
|
| PRK13055 |
PRK13055 |
putative lipid kinase; Reviewed |
1-293 |
2.45e-64 |
|
putative lipid kinase; Reviewed
Pssm-ID: 237282 [Multi-domain] Cd Length: 334 Bit Score: 205.22 E-value: 2.45e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGD-AKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAE 79
Cdd:PRK13055 2 QKRARLIYNPTSGQEIMKKNVADILDILEQAGYETSAFQTTPEPNsAKNEAKRAAEAGFDLIIAAGGDGTINEVVNGIAP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 80 QEHRPNFGFFPLGTVNDLARALGIPL-EPEEAIKHFSIESVKPLDIGKINDD-YFMNVVAIGSIPEAINDVDAEKKTKFG 157
Cdd:PRK13055 82 LEKRPKMAIIPAGTTNDYARALKIPRdNPVEAAKVILKNQTIKMDIGRANEDkYFINIAAGGSLTELTYSVPSQLKSMFG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 158 KLAYFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPD 237
Cdd:PRK13055 162 YLAYLAKGAELLPRVSPVPVRITYDEGVFEGKISMFFLALTNSVGGFEQIVPDAKLDDGKFTLIIVKTANLFELLHLMAL 241
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 488302628 238 LLKG---VDgsTKNLAYLTCEQLVVSLADEEELTTNVDGDEGDKLPVNIKVLPSHLQVY 293
Cdd:PRK13055 242 ILNGgkhID--DPRVIYIKTSKLTIEPLGDDRLMVNLDGEYGGDAPMTFENLKQHIEFF 298
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-292 |
1.52e-58 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 189.25 E-value: 1.52e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALIQL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDY-FMNVVAIGSIPEAINDVDAEKKTKFGKL 159
Cdd:TIGR00147 81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 160 AYFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLL 239
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPALVLTLMSD 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 488302628 240 KGVDGSTKNLAYLTCEQlvVSLADEEELTTNVDGDEGDKLPVNIKVLPSHLQV 292
Cdd:TIGR00147 241 EGKHTDNPNIIYGKASR--IDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| PRK13054 |
PRK13054 |
lipid kinase; Reviewed |
1-293 |
7.81e-44 |
|
lipid kinase; Reviewed
Pssm-ID: 237281 [Multi-domain] Cd Length: 300 Bit Score: 151.18 E-value: 7.81e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNpssgGEQAKEfEQL--AIEKLEsvfDEVVVLH---TKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGIS 75
Cdd:PRK13054 3 FPKSLLILN----GKSAGN-EELreAVGLLR---EEGHTLHvrvTWEKGDAARYVEEALALGVATVIAGGGDGTINEVAT 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 76 GIA--EQEHRPNFGFFPLGTVNDLARALGIPLEPEEAIKhFSIE-SVKPLDIGKINDD-YFMNVVAIGSIPEAINDVDAE 151
Cdd:PRK13054 75 ALAqlEGDARPALGILPLGTANDFATAAGIPLEPDKALK-LAIEgRAQPIDLARVNDRtYFINMATGGFGTRVTTETPEK 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 152 KKTKFGKLAYFMSGIKQLASTQSYSfhVEVDGKKEEIESSTLLIGLTNS--VGGFETLLPNAKVDDGKLHLVYLKdsSLI 229
Cdd:PRK13054 154 LKAALGGVAYLIHGLMRMDTLKPDR--CEIRGPDFHWQGDALVIGIGNGrqAGGGQQLCPEALINDGLLDLRILP--APQ 229
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 488302628 230 DTLKTLPDLLKGVDGSTKNLAYLTCEQLVVSLAdeEELTTNVDGD--EGDKLpvNIKVLPSHLQVY 293
Cdd:PRK13054 230 ELLPTLLSTLTGGSEDNPNIIRARLPWLEIQAP--HELTFNLDGEplSGRHF--RIEVLPAALRCR 291
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-127 |
5.82e-43 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 143.49 E-value: 5.82e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 3 KVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQEH 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....*
gi 488302628 83 RPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKI 127
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGKV 125
|
|
| PRK13057 |
PRK13057 |
lipid kinase; |
5-293 |
3.92e-37 |
|
lipid kinase;
Pssm-ID: 183857 [Multi-domain] Cd Length: 287 Bit Score: 133.50 E-value: 3.92e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 5 LLVVNPSSggEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAvEGYHSVFVMGGDGTVNEGISGIAEQehRP 84
Cdd:PRK13057 1 LLLVNRHA--RSGRAALAAARAALEAAGLELVEPPAEDPDDLSEVIEAYA-DGVDLVIVGGGDGTLNAAAPALVET--GL 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 85 NFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFGKLAYFMS 164
Cdd:PRK13057 76 PLGILPLGTANDLARTLGIPLDLEAAARVIATGQVRRIDLGWVNGHYFFNVASLGLSAELARRLTKELKRRWGTLGYAIA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 165 GIKQLASTQSYSFHVEVDGKKEEIEssTLLIGLTNSV--GGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLKGV 242
Cdd:PRK13057 156 ALRVLRRSRPFTAEIEHDGRTERVK--TLQVAVGNGRyyGGGMTVAHDATIDDGRLDLYSLEVAHWWRLLALLPALRRGR 233
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|.
gi 488302628 243 DGSTKNLAYLTCEQLVVSLADEEELttNVDGDEGDKLPVNIKVLPSHLQVY 293
Cdd:PRK13057 234 HGEWPDVRAFRTTELELRTRKPRPI--NTDGELTTYTPAHFRVLPKALRVL 282
|
|
| PRK13059 |
PRK13059 |
putative lipid kinase; Reviewed |
1-292 |
1.33e-36 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183858 Cd Length: 295 Bit Score: 132.08 E-value: 1.33e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGgeqakefEQLAIEKLesvfDEVVVLHTKKAGDA------KNFTREAAV----EGYHSVFVMGGDGTV 70
Cdd:PRK13059 1 MKKVKFIYNPYSG-------ENAIISEL----DKVIRIHQEKGYLVvpyrisLEYDLKNAFkdidESYKYILIAGGDGTV 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 71 NEGISGIAEQEHRPNFGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDA 150
Cdd:PRK13059 70 DNVVNAMKKLNIDLPIGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDKYFINVASTGLFTDVSQKTDV 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 151 EKKTKFGKLAYFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLLIGLTNSVGGFEtLLPNAKVDDGKLHLVYLKDSSLID 230
Cdd:PRK13059 150 NLKNTIGKLAYYLKGLEELPNFRKLKVKVTSEEVNFDGDMYLMLVFNGQTAGNFN-LAYKAEVDDGLLDVIIIKACPIID 228
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 488302628 231 TLKTLPDLLKG--VDgSTKNLAYLTCEQLVVSlaDEEELTTNVDGDEGDKLPVNIKVLPSHLQV 292
Cdd:PRK13059 229 LIPLFIKVLKGehLE-DVNGLIYFKTDKLEIE--SNEEIVTDIDGERGPDFPLNIECIKGGLKV 289
|
|
| PRK12361 |
PRK12361 |
hypothetical protein; Provisional |
2-294 |
3.57e-26 |
|
hypothetical protein; Provisional
Pssm-ID: 183473 [Multi-domain] Cd Length: 547 Bit Score: 107.78 E-value: 3.57e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 2 KKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDeVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQE 81
Cdd:PRK12361 243 KRAWLIANPVSGGGKWQEYGEQIQRELKAYFD-LTVKLTTPEISAEALAKQARKAGADIVIACGGDGTVTEVASELVNTD 321
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 82 HRpnFGFFPLGTVNDLARAL---GIPLEP-EEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFG 157
Cdd:PRK12361 322 IT--LGIIPLGTANALSHALfglGSKLIPvEQACDNIIQGHTQRIDTARCNDRLMLLLVGIGFEQKMIESADRERKNALG 399
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 158 KLAYFMSGIKQLASTQSYSFHVEVDGKK-EEIESSTLLIGltnSVGGFETLL------PNakVDDGKLHLVYL-KDSSLI 229
Cdd:PRK12361 400 QLAYLDGLWRAVNENETLTLTVTLDDAEpQTISTHSLVVA---NAAPFTSLLaqgggePN--MTDGLLDITWLdSGGEPG 474
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 230 DTLKTLPDL-LKGVDGS--TKNLAYLTCEqlVVSLADEEELTTNVDGD--EGDKLpvNIKVLPSHLQVYC 294
Cdd:PRK12361 475 EQLLSLAELaLSGLGKEpeANKVHHAHAK--KVTISSQKPIKYVIDGElfEDEDL--TIEVQPASLKVFV 540
|
|
| PRK00861 |
PRK00861 |
putative lipid kinase; Reviewed |
1-293 |
1.35e-25 |
|
putative lipid kinase; Reviewed
Pssm-ID: 234850 [Multi-domain] Cd Length: 300 Bit Score: 103.16 E-value: 1.35e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSG-GEQAKEFEQLAiEKLESVFDEVVVLHTKKAGdAKNFTREAAVEGYHSVFVMGGDGTvnegISGIAE 79
Cdd:PRK00861 2 TRSACLIFNPVAGqGNPEVDLALIR-AILEPEMDLDIYLTTPEIG-ADQLAQEAIERGAELIIASGGDGT----LSAVAG 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 80 QEHRPN--FGFFPLGTVNDLARALGIPLEPEEAIKHFSIESVKPLDIGKINDDYFMNVVAIGSIPEAINDVDAEKKTKFG 157
Cdd:PRK00861 76 ALIGTDipLGIIPRGTANAFAAALGIPDTIEEACRTILQGKTRRVDVAYCNGQPMILLAGIGFEAETVEEADREAKNRFG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 158 KLAYFMSGIKQLASTQSYSFHVEVDGKKeeIESSTLLIGLTN-----SV--GGFETLLPnakvDDGKLHLVYLKDSSLID 230
Cdd:PRK00861 156 ILAYILSGLQQLRELESFEVEIETEDQI--ITTNAVAVTVANaapptSVlaQGPGAVIP----DDGLLDVTIVAPKNLAE 229
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 488302628 231 TLKTLPDLL-KGVDGST---KNLAYLTCEQLVVSLADEEELTtnVDGDEGDKLPVNIKVLPSHLQVY 293
Cdd:PRK00861 230 AVAASYHLLqTALQGNPaerDDIGYLRAKQVKITTDPPQKVV--IDGEVVGTTPIEIECLPRSLKVF 294
|
|
| PRK11914 |
PRK11914 |
diacylglycerol kinase; Reviewed |
1-292 |
1.38e-22 |
|
diacylglycerol kinase; Reviewed
Pssm-ID: 237021 [Multi-domain] Cd Length: 306 Bit Score: 94.85 E-value: 1.38e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 1 MKKVLLVVNPSSGGEQAKEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:PRK11914 8 IGKVTVLTNPLSGHGAAPHAAERAIARLHHRGVDVVEIVGTDAHDARHLVAAALAKGTDALVVVGGDGVISNALQVLAGT 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EhRPnFGFFPLGTVNDLARALGIPL-EPEEAIKHFSIESVKPLDIGKINDD-----YFMNVVAIGsIPEAINDVDAEKKT 154
Cdd:PRK11914 88 D-IP-LGIIPAGTGNDHAREFGIPTgDPEAAADVIVDGWTETVDLGRIQDDdgivkWFGTVAATG-FDSLVTDRANRMRW 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 155 KFGKLAYFMSGIKQLASTQSYSFHVEVDGKKEEIESSTLL-IGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLK 233
Cdd:PRK11914 165 PHGRMRYNLAMLAELSKLRPLPFRLVLDGTEEIVTDLTLAaFGNTRSYGGGMLICPNADHTDGLLDITMVQSASRTRLLR 244
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 488302628 234 TLPDLLKGvdgSTKNLAYLTCEQLVVSLADEEELTTNVDGDEGDKLPVNIKVLPSHLQV 292
Cdd:PRK11914 245 LFPTVFKG---THVELDEVSTARAKTVHVECPGINAYADGDFACPLPAEISAVPGALQI 300
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-108 |
1.13e-13 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 66.55 E-value: 1.13e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 5 LLVVNPSSGGEQAKEFeqlaIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQE--- 81
Cdd:smart00046 1 LVFVNPKSGGGKGEKL----LRKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRElpl 76
|
90 100
....*....|....*....|....*..
gi 488302628 82 HRPNFGFFPLGTVNDLARALGIPLEPE 108
Cdd:smart00046 77 PEPPVAVLPLGTGNDLARSLGWGGGYD 103
|
|
| YegS_C |
pfam19279 |
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ... |
156-294 |
2.14e-10 |
|
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.
Pssm-ID: 437111 Cd Length: 158 Bit Score: 57.98 E-value: 2.14e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 156 FGKLAYFMSGIKQLASTQSYSFHVEVDGkkEEIESSTLLIGLTNS--VGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLK 233
Cdd:pfam19279 22 PGALSYPAAALRALATFRPLRYRVTVDG--EVREFSAALVAVANSgyYGGGMRIAPDARVDDGLLDVVVIEAASRRTLLR 99
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 488302628 234 TLPDLLkgvDGSTKNLAYLTCEQL-VVSLADEEELTTNVDGDEGDKLPVNIKVLPSHLQVYC 294
Cdd:pfam19279 100 LLPKVY---DGRHVRLPQVEVLRGrEVRIEADRPLPAGADGEVLGPLPVRVEVLPGALRVLA 158
|
|
| PLN02958 |
PLN02958 |
diacylglycerol kinase/D-erythro-sphingosine kinase |
2-259 |
7.99e-06 |
|
diacylglycerol kinase/D-erythro-sphingosine kinase
Pssm-ID: 215517 [Multi-domain] Cd Length: 481 Bit Score: 46.78 E-value: 7.99e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 2 KKVLLVVNPSSGGEQA-KEFEQLAIEKLESVFDEVVVLHTKKAGDAKNFTREAAVEGYHSVFVMGGDGTVNEGISGIAEQ 80
Cdd:PLN02958 112 KRLLVFVNPFGGKKSAsKIFFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLLER 191
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 81 EH-----RPNFGFFPLGTVNDLARAL----GIPLEPEEAIKHFSIESVKPLDIGKI--NDDYFMNVVAIGSIPEAINDVD 149
Cdd:PLN02958 192 EDwktaiKLPIGMVPAGTGNGMAKSLldsvGEPCSATNAVLAIIRGHKCSLDVATIlqGETKFFSVLMLAWGLVADIDIE 271
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 488302628 150 AEKKTKFGKLAYFMSGIKQLASTQSY-------------------SFHVEVDGKKEEIESSTLL-----IGLTN------ 199
Cdd:PLN02958 272 SEKYRWMGSARLDFYGLQRILCLRQYngrisfvpapgfeaygeptSYNGESTSKEESGKDKQHGyqgpdVKLENldwrti 351
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 488302628 200 -----SV-------GGFETL-LPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLKGVDGSTKNLAYLTCEQLVV 259
Cdd:PLN02958 352 kgpfvSVwlhnvpwGGEDTLaAPDAKFSDGYLDLILIKDCPKLALLALMTKLSDGTHVKSPYVMYLKVKAFVL 424
|
|
|